LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Gbx1

    Buckley, Desirè M / Burroughs-Garcia, Jessica / Kriks, Sonja / Lewandoski, Mark / Waters, Samuel T

    Journal of developmental biology

    2020  Volume 8, Issue 2

    Abstract: The molecular mechanisms regulating neurogenesis involve the control of gene expression by transcription factors. ...

    Abstract The molecular mechanisms regulating neurogenesis involve the control of gene expression by transcription factors.
    Language English
    Publishing date 2020-04-01
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720870-9
    ISSN 2221-3759 ; 2221-3759
    ISSN (online) 2221-3759
    ISSN 2221-3759
    DOI 10.3390/jdb8020009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Gbx1 and Gbx2 Are Essential for Normal Patterning and Development of Interneurons and Motor Neurons in the Embryonic Spinal Cord

    Buckley, Desirè M. / Burroughs-Garcia, Jessica / Kriks, Sonja / Lewandoski, Mark / Waters, Samuel T.

    Journal of developmental biology. 2020 Apr. 01, v. 8, no. 2

    2020  

    Abstract: The molecular mechanisms regulating neurogenesis involve the control of gene expression by transcription factors. Gbx1 and Gbx2, two members of the Gbx family of homeodomain-containing transcription factors, are known for their essential roles in central ...

    Abstract The molecular mechanisms regulating neurogenesis involve the control of gene expression by transcription factors. Gbx1 and Gbx2, two members of the Gbx family of homeodomain-containing transcription factors, are known for their essential roles in central nervous system development. The expression domains of mouse Gbx1 and Gbx2 include regions of the forebrain, anterior hindbrain, and spinal cord. In the spinal cord, Gbx1 and Gbx2 are expressed in PAX2⁺ interneurons of the dorsal horn and ventral motor neuron progenitors. Based on their shared domains of expression and instances of overlap, we investigated the functional relationship between Gbx family members in the developing spinal cord using Gbx1⁻/⁻, Gbx2⁻/⁻, and Gbx1⁻/⁻/Gbx2⁻/⁻ embryos. In situ hybridization analyses of embryonic spinal cords show upregulation of Gbx2 expression in Gbx1⁻/⁻ embryos and upregulation of Gbx1 expression in Gbx2⁻/⁻ embryos. Additionally, our data demonstrate that Gbx genes regulate development of a subset of PAX2⁺ dorsal inhibitory interneurons. While we observe no difference in overall proliferative status of the developing ependymal layer, expansion of proliferative cells into the anatomically defined mantle zone occurs in Gbx mutants. Lastly, our data shows a marked increase in apoptotic cell death in the ventral spinal cord of Gbx mutants during mid-embryonic stages. While our studies reveal that both members of the Gbx gene family are involved in development of subsets of PAX2⁺ dorsal interneurons and survival of ventral motor neurons, Gbx1 and Gbx2 are not sufficient to genetically compensate for the loss of one another. Thus, our studies provide novel insight to the relationship harbored between Gbx1 and Gbx2 in spinal cord development.
    Keywords apoptosis ; brain ; gene expression ; genes ; hybridization ; interneurons ; mice ; motor neurons ; neurodevelopment ; neurogenesis ; spinal cord
    Language English
    Dates of publication 2020-0401
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2720870-9
    ISSN 2221-3759
    ISSN 2221-3759
    DOI 10.3390/jdb8020009
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Gbx1 and Gbx2 Are Essential for Normal Patterning and Development of Interneurons and Motor Neurons in the Embryonic Spinal Cord

    Desirè M. Buckley / Jessica Burroughs-Garcia / Sonja Kriks / Mark Lewandoski / Samuel T. Waters

    Journal of Developmental Biology, Vol 8, Iss 9, p

    2020  Volume 9

    Abstract: The molecular mechanisms regulating neurogenesis involve the control of gene expression by transcription factors. Gbx1 and Gbx2 , two members of the Gbx family of homeodomain-containing transcription factors, are known for their essential roles in ... ...

    Abstract The molecular mechanisms regulating neurogenesis involve the control of gene expression by transcription factors. Gbx1 and Gbx2 , two members of the Gbx family of homeodomain-containing transcription factors, are known for their essential roles in central nervous system development. The expression domains of mouse Gbx1 and Gbx2 include regions of the forebrain, anterior hindbrain, and spinal cord. In the spinal cord, Gbx1 and Gbx2 are expressed in PAX2 + interneurons of the dorsal horn and ventral motor neuron progenitors. Based on their shared domains of expression and instances of overlap, we investigated the functional relationship between Gbx family members in the developing spinal cord using Gbx1 −/− , Gbx2 −/− , and Gbx1 −/− / Gbx2 −/− embryos. In situ hybridization analyses of embryonic spinal cords show upregulation of Gbx2 expression in Gbx1 −/− embryos and upregulation of Gbx1 expression in Gbx2 −/− embryos. Additionally, our data demonstrate that Gbx genes regulate development of a subset of PAX2 + dorsal inhibitory interneurons. While we observe no difference in overall proliferative status of the developing ependymal layer, expansion of proliferative cells into the anatomically defined mantle zone occurs in Gbx mutants. Lastly, our data shows a marked increase in apoptotic cell death in the ventral spinal cord of Gbx mutants during mid-embryonic stages. While our studies reveal that both members of the Gbx gene family are involved in development of subsets of PAX2 + dorsal interneurons and survival of ventral motor neurons, Gbx1 and Gbx2 are not sufficient to genetically compensate for the loss of one another. Thus, our studies provide novel insight to the relationship harbored between Gbx1 and Gbx2 in spinal cord development.
    Keywords Gbx1 ; Gbx2 ; spinal cord ; mouse ; development ; Biology (General) ; QH301-705.5
    Subject code 333
    Language English
    Publishing date 2020-04-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

    Payne, Thomas / Appleby, Matthew / Buckley, Ellen / van Gelder, Linda M A / Mullish, Benjamin H / Sassani, Matilde / Dunning, Mark J / Hernandez, Dena / Scholz, Sonja W / McNeill, Alisdair / Libri, Vincenzo / Moll, Sarah / Marchesi, Julian R / Taylor, Rosie / Su, Li / Mazzà, Claudia / Jenkins, Thomas M / Foltynie, Thomas / Bandmann, Oliver

    Movement disorders : official journal of the Movement Disorder Society

    2023  Volume 38, Issue 8, Page(s) 1493–1502

    Abstract: Background: Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across a range of preclinical in vitro and in ... ...

    Abstract Background: Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across a range of preclinical in vitro and in vivo models of PD.
    Objectives: To investigate the safety and tolerability of high-dose UDCA in PD and determine midbrain target engagement.
    Methods: The UP (UDCA in PD) study was a phase II, randomized, double-blind, placebo-controlled trial of UDCA (30 mg/kg daily, 2:1 randomization UDCA vs. placebo) in 30 participants with PD for 48 weeks. The primary outcome was safety and tolerability. Secondary outcomes included 31-phosphorus magnetic resonance spectroscopy (
    Results: UDCA was safe and well tolerated, and only mild transient gastrointestinal adverse events were more frequent in the UDCA treatment group. Midbrain
    Conclusions: High-dose UDCA is safe and well tolerated in early PD. Larger trials are needed to further evaluate the disease-modifying effect of UDCA in PD. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
    MeSH term(s) Humans ; Parkinson Disease/complications ; Ursodeoxycholic Acid/therapeutic use ; Double-Blind Method
    Chemical Substances Ursodeoxycholic Acid (724L30Y2QR)
    Language English
    Publishing date 2023-05-29
    Publishing country United States
    Document type Randomized Controlled Trial ; Clinical Trial, Phase II ; Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 607633-6
    ISSN 1531-8257 ; 0885-3185
    ISSN (online) 1531-8257
    ISSN 0885-3185
    DOI 10.1002/mds.29450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.

    Peacock, Amy / Gisev, Natasa / Memedovic, Sonja / Larance, Briony / Brown, Jared / Cairns, Rose / Buckley, Nicholas / Farrell, Michael / Degenhardt, Louisa

    Drug and alcohol dependence

    2019  Volume 206, Page(s) 107697

    Abstract: Aims: A sustained-release formulation (SRF) of tapentadol has been marketed in Australia since February 2013. This study examined tapentadol SRF extra-medical use, attractiveness for extra-medical use, and associated harms in Australia.: Methods: ... ...

    Abstract Aims: A sustained-release formulation (SRF) of tapentadol has been marketed in Australia since February 2013. This study examined tapentadol SRF extra-medical use, attractiveness for extra-medical use, and associated harms in Australia.
    Methods: This post-marketing study comprises analyses of Australian community sales data (2011-2017) for eleven pharmaceutical opioids (prescription and over-the-counter codeine disaggregated); calls to three poisons information centres (covering five of the eight jurisdictions in Australia) related to pharmaceutical opioids and coded by the centres as 'misuse' or 'abuse' (2011-2017); and interviews with people who inject drugs (n = 888) recruited as part of the Illicit Drug Reporting System (IDRS) from all Australian capital cities (2017).
    Results: Population-level availability of tapentadol SRF increased from market launch, comprising the sixth largest market share of all opioid unit sales, and third greatest share in oral morphine equivalent milligrams sold, in December 2017. Lifetime tapentadol SRF use among the IDRS sample (n = 888) was low (1.5%; 95%CI 0.9-2.5), with few reporting past-6 month non-prescribed use or injection. Non-fatal overdose following tapentadol use was self-reported by less than 1% (95%CI 0.1-0.8). Between 2013-2017, 1.1% (n = 25) of pharmaceutical opioid 'misuse/abuse' calls were related to tapentadol, and predominantly the SRF.
    Conclusions: Increasing utilisation of tapentadol sustained-release formulation was observed, along with indications of extra-medical use and harms associated with use, although on a smaller scale relative to other opioids. These findings need to be interpreted in the context of the low level of exposure to tapentadol sustained-release formulation among the sentinel population of people who inject drugs.
    MeSH term(s) Adult ; Australia ; Delayed-Action Preparations/adverse effects ; Drug Overdose/epidemiology ; Drug Utilization/statistics & numerical data ; Female ; Humans ; Male ; Opioid-Related Disorders/epidemiology ; Product Surveillance, Postmarketing/statistics & numerical data ; Self Medication ; Substance Abuse, Intravenous/epidemiology ; Tapentadol/adverse effects ; Tapentadol/economics ; Young Adult
    Chemical Substances Delayed-Action Preparations ; Tapentadol (H8A007M585)
    Language English
    Publishing date 2019-11-01
    Publishing country Ireland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 519918-9
    ISSN 1879-0046 ; 0376-8716
    ISSN (online) 1879-0046
    ISSN 0376-8716
    DOI 10.1016/j.drugalcdep.2019.107697
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity.

    Cheng, Hanyin / Capponi, Simona / Wakeling, Emma / Marchi, Elaine / Li, Quan / Zhao, Mengge / Weng, Chunhua / Stefan, Piatek G / Ahlfors, Helena / Kleyner, Robert / Rope, Alan / Lumaka, Aimé / Lukusa, Prosper / Devriendt, Koenraad / Vermeesch, Joris / Posey, Jennifer E / Palmer, Elizabeth E / Murray, Lucinda / Leon, Eyby /
    Diaz, Jullianne / Worgan, Lisa / Mallawaarachchi, Amalia / Vogt, Julie / de Munnik, Sonja A / Dreyer, Lauren / Baynam, Gareth / Ewans, Lisa / Stark, Zornitza / Lunke, Sebastian / Gonçalves, Ana R / Soares, Gabriela / Oliveira, Jorge / Fassi, Emily / Willing, Marcia / Waugh, Jeff L / Faivre, Laurence / Riviere, Jean-Baptiste / Moutton, Sebastien / Mohammed, Shehla / Payne, Katelyn / Walsh, Laurence / Begtrup, Amber / Guillen Sacoto, Maria J / Douglas, Ganka / Alexander, Nora / Buckley, Michael F / Mark, Paul R / Adès, Lesley C / Sandaradura, Sarah A / Lupski, James R / Roscioli, Tony / Agrawal, Pankaj B / Kline, Antonie D / Wang, Kai / Timmers, H T Marc / Lyon, Gholson J

    Human mutation

    2019  

    Abstract: We recently described a new neurodevelopmental syndrome (TAF1/MRXS33 intellectual disability syndrome) (MIM# 300966) caused by pathogenic variants involving the X-linked gene TAF1, which participates in RNA polymerase II transcription. The initial study ... ...

    Abstract We recently described a new neurodevelopmental syndrome (TAF1/MRXS33 intellectual disability syndrome) (MIM# 300966) caused by pathogenic variants involving the X-linked gene TAF1, which participates in RNA polymerase II transcription. The initial study reported eleven families, and the syndrome was defined as presenting early in life with hypotonia, facial dysmorphia, and developmental delay that evolved into intellectual disability (ID) and/or autism spectrum disorder (ASD). We have now identified an additional 27 families through a genotype-first approach. Familial segregation analysis, clinical phenotyping, and bioinformatics were capitalized on to assess potential variant pathogenicity, and molecular modelling was performed for those variants falling within structurally characterized domains of TAF1. A novel phenotypic clustering approach was also applied, in which the phenotypes of affected individuals were classified using 51 standardized Human Phenotype Ontology (HPO) terms. Phenotypes associated with TAF1 variants show considerable pleiotropy and clinical variability, but prominent among previously unreported effects were brain morphological abnormalities, seizures, hearing loss, and heart malformations. Our allelic series broadens the phenotypic spectrum of TAF1/MRXS33 intellectual disability syndrome and the range of TAF1 molecular defects in humans. It also illustrates the challenges for determining the pathogenicity of inherited missense variants, particularly for genes mapping to chromosome X. This article is protected by copyright. All rights reserved.
    Language English
    Publishing date 2019-10-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1126646-6
    ISSN 1098-1004 ; 1059-7794
    ISSN (online) 1098-1004
    ISSN 1059-7794
    DOI 10.1002/humu.23936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Defining the role of common variation in the genomic and biological architecture of adult human height.

    Wood, Andrew R / Esko, Tonu / Yang, Jian / Vedantam, Sailaja / Pers, Tune H / Gustafsson, Stefan / Chu, Audrey Y / Estrada, Karol / Luan, Jian'an / Kutalik, Zoltán / Amin, Najaf / Buchkovich, Martin L / Croteau-Chonka, Damien C / Day, Felix R / Duan, Yanan / Fall, Tove / Fehrmann, Rudolf / Ferreira, Teresa / Jackson, Anne U /
    Karjalainen, Juha / Lo, Ken Sin / Locke, Adam E / Mägi, Reedik / Mihailov, Evelin / Porcu, Eleonora / Randall, Joshua C / Scherag, André / Vinkhuyzen, Anna A E / Westra, Harm-Jan / Winkler, Thomas W / Workalemahu, Tsegaselassie / Zhao, Jing Hua / Absher, Devin / Albrecht, Eva / Anderson, Denise / Baron, Jeffrey / Beekman, Marian / Demirkan, Ayse / Ehret, Georg B / Feenstra, Bjarke / Feitosa, Mary F / Fischer, Krista / Fraser, Ross M / Goel, Anuj / Gong, Jian / Justice, Anne E / Kanoni, Stavroula / Kleber, Marcus E / Kristiansson, Kati / Lim, Unhee / Lotay, Vaneet / Lui, Julian C / Mangino, Massimo / Mateo Leach, Irene / Medina-Gomez, Carolina / Nalls, Michael A / Nyholt, Dale R / Palmer, Cameron D / Pasko, Dorota / Pechlivanis, Sonali / Prokopenko, Inga / Ried, Janina S / Ripke, Stephan / Shungin, Dmitry / Stancáková, Alena / Strawbridge, Rona J / Sung, Yun Ju / Tanaka, Toshiko / Teumer, Alexander / Trompet, Stella / van der Laan, Sander W / van Setten, Jessica / Van Vliet-Ostaptchouk, Jana V / Wang, Zhaoming / Yengo, Loïc / Zhang, Weihua / Afzal, Uzma / Arnlöv, Johan / Arscott, Gillian M / Bandinelli, Stefania / Barrett, Amy / Bellis, Claire / Bennett, Amanda J / Berne, Christian / Blüher, Matthias / Bolton, Jennifer L / Böttcher, Yvonne / Boyd, Heather A / Bruinenberg, Marcel / Buckley, Brendan M / Buyske, Steven / Caspersen, Ida H / Chines, Peter S / Clarke, Robert / Claudi-Boehm, Simone / Cooper, Matthew / Daw, E Warwick / De Jong, Pim A / Deelen, Joris / Delgado, Graciela / Denny, Josh C / Dhonukshe-Rutten, Rosalie / Dimitriou, Maria / Doney, Alex S F / Dörr, Marcus / Eklund, Niina / Eury, Elodie / Folkersen, Lasse / Garcia, Melissa E / Geller, Frank / Giedraitis, Vilmantas / Go, Alan S / Grallert, Harald / Grammer, Tanja B / Gräßler, Jürgen / Grönberg, Henrik / de Groot, Lisette C P G M / Groves, Christopher J / Haessler, Jeffrey / Hall, Per / Haller, Toomas / Hallmans, Goran / Hannemann, Anke / Hartman, Catharina A / Hassinen, Maija / Hayward, Caroline / Heard-Costa, Nancy L / Helmer, Quinta / Hemani, Gibran / Henders, Anjali K / Hillege, Hans L / Hlatky, Mark A / Hoffmann, Wolfgang / Hoffmann, Per / Holmen, Oddgeir / Houwing-Duistermaat, Jeanine J / Illig, Thomas / Isaacs, Aaron / James, Alan L / Jeff, Janina / Johansen, Berit / Johansson, Åsa / Jolley, Jennifer / Juliusdottir, Thorhildur / Junttila, Juhani / Kho, Abel N / Kinnunen, Leena / Klopp, Norman / Kocher, Thomas / Kratzer, Wolfgang / Lichtner, Peter / Lind, Lars / Lindström, Jaana / Lobbens, Stéphane / Lorentzon, Mattias / Lu, Yingchang / Lyssenko, Valeriya / Magnusson, Patrik K E / Mahajan, Anubha / Maillard, Marc / McArdle, Wendy L / McKenzie, Colin A / McLachlan, Stela / McLaren, Paul J / Menni, Cristina / Merger, Sigrun / Milani, Lili / Moayyeri, Alireza / Monda, Keri L / Morken, Mario A / Müller, Gabriele / Müller-Nurasyid, Martina / Musk, Arthur W / Narisu, Narisu / Nauck, Matthias / Nolte, Ilja M / Nöthen, Markus M / Oozageer, Laticia / Pilz, Stefan / Rayner, Nigel W / Renstrom, Frida / Robertson, Neil R / Rose, Lynda M / Roussel, Ronan / Sanna, Serena / Scharnagl, Hubert / Scholtens, Salome / Schumacher, Fredrick R / Schunkert, Heribert / Scott, Robert A / Sehmi, Joban / Seufferlein, Thomas / Shi, Jianxin / Silventoinen, Karri / Smit, Johannes H / Smith, Albert Vernon / Smolonska, Joanna / Stanton, Alice V / Stirrups, Kathleen / Stott, David J / Stringham, Heather M / Sundström, Johan / Swertz, Morris A / Syvänen, Ann-Christine / Tayo, Bamidele O / Thorleifsson, Gudmar / Tyrer, Jonathan P / van Dijk, Suzanne / van Schoor, Natasja M / van der Velde, Nathalie / van Heemst, Diana / van Oort, Floor V A / Vermeulen, Sita H / Verweij, Niek / Vonk, Judith M / Waite, Lindsay L / Waldenberger, Melanie / Wennauer, Roman / Wilkens, Lynne R / Willenborg, Christina / Wilsgaard, Tom / Wojczynski, Mary K / Wong, Andrew / Wright, Alan F / Zhang, Qunyuan / Arveiler, Dominique / Bakker, Stephan J L / Beilby, John / Bergman, Richard N / Bergmann, Sven / Biffar, Reiner / Blangero, John / Boomsma, Dorret I / Bornstein, Stefan R / Bovet, Pascal / Brambilla, Paolo / Brown, Morris J / Campbell, Harry / Caulfield, Mark J / Chakravarti, Aravinda / Collins, Rory / Collins, Francis S / Crawford, Dana C / Cupples, L Adrienne / Danesh, John / de Faire, Ulf / den Ruijter, Hester M / Erbel, Raimund / Erdmann, Jeanette / Eriksson, Johan G / Farrall, Martin / Ferrannini, Ele / Ferrières, Jean / Ford, Ian / Forouhi, Nita G / Forrester, Terrence / Gansevoort, Ron T / Gejman, Pablo V / Gieger, Christian / Golay, Alain / Gottesman, Omri / Gudnason, Vilmundur / Gyllensten, Ulf / Haas, David W / Hall, Alistair S / Harris, Tamara B / Hattersley, Andrew T / Heath, Andrew C / Hengstenberg, Christian / Hicks, Andrew A / Hindorff, Lucia A / Hingorani, Aroon D / Hofman, Albert / Hovingh, G Kees / Humphries, Steve E / Hunt, Steven C / Hypponen, Elina / Jacobs, Kevin B / Jarvelin, Marjo-Riitta / Jousilahti, Pekka / Jula, Antti M / Kaprio, Jaakko / Kastelein, John J P / Kayser, Manfred / Kee, Frank / Keinanen-Kiukaanniemi, Sirkka M / Kiemeney, Lambertus A / Kooner, Jaspal S / Kooperberg, Charles / Koskinen, Seppo / Kovacs, Peter / Kraja, Aldi T / Kumari, Meena / Kuusisto, Johanna / Lakka, Timo A / Langenberg, Claudia / Le Marchand, Loic / Lehtimäki, Terho / Lupoli, Sara / Madden, Pamela A F / Männistö, Satu / Manunta, Paolo / Marette, André / Matise, Tara C / McKnight, Barbara / Meitinger, Thomas / Moll, Frans L / Montgomery, Grant W / Morris, Andrew D / Morris, Andrew P / Murray, Jeffrey C / Nelis, Mari / Ohlsson, Claes / Oldehinkel, Albertine J / Ong, Ken K / Ouwehand, Willem H / Pasterkamp, Gerard / Peters, Annette / Pramstaller, Peter P / Price, Jackie F / Qi, Lu / Raitakari, Olli T / Rankinen, Tuomo / Rao, D C / Rice, Treva K / Ritchie, Marylyn / Rudan, Igor / Salomaa, Veikko / Samani, Nilesh J / Saramies, Jouko / Sarzynski, Mark A / Schwarz, Peter E H / Sebert, Sylvain / Sever, Peter / Shuldiner, Alan R / Sinisalo, Juha / Steinthorsdottir, Valgerdur / Stolk, Ronald P / Tardif, Jean-Claude / Tönjes, Anke / Tremblay, Angelo / Tremoli, Elena / Virtamo, Jarmo / Vohl, Marie-Claude / Amouyel, Philippe / Asselbergs, Folkert W / Assimes, Themistocles L / Bochud, Murielle / Boehm, Bernhard O / Boerwinkle, Eric / Bottinger, Erwin P / Bouchard, Claude / Cauchi, Stéphane / Chambers, John C / Chanock, Stephen J / Cooper, Richard S / de Bakker, Paul I W / Dedoussis, George / Ferrucci, Luigi / Franks, Paul W / Froguel, Philippe / Groop, Leif C / Haiman, Christopher A / Hamsten, Anders / Hayes, M Geoffrey / Hui, Jennie / Hunter, David J / Hveem, Kristian / Jukema, J Wouter / Kaplan, Robert C / Kivimaki, Mika / Kuh, Diana / Laakso, Markku / Liu, Yongmei / Martin, Nicholas G / März, Winfried / Melbye, Mads / Moebus, Susanne / Munroe, Patricia B / Njølstad, Inger / Oostra, Ben A / Palmer, Colin N A / Pedersen, Nancy L / Perola, Markus / Pérusse, Louis / Peters, Ulrike / Powell, Joseph E / Power, Chris / Quertermous, Thomas / Rauramaa, Rainer / Reinmaa, Eva / Ridker, Paul M / Rivadeneira, Fernando / Rotter, Jerome I / Saaristo, Timo E / Saleheen, Danish / Schlessinger, David / Slagboom, P Eline / Snieder, Harold / Spector, Tim D / Strauch, Konstantin / Stumvoll, Michael / Tuomilehto, Jaakko / Uusitupa, Matti / van der Harst, Pim / Völzke, Henry / Walker, Mark / Wareham, Nicholas J / Watkins, Hugh / Wichmann, H-Erich / Wilson, James F / Zanen, Pieter / Deloukas, Panos / Heid, Iris M / Lindgren, Cecilia M / Mohlke, Karen L / Speliotes, Elizabeth K / Thorsteinsdottir, Unnur / Barroso, Inês / Fox, Caroline S / North, Kari E / Strachan, David P / Beckmann, Jacques S / Berndt, Sonja I / Boehnke, Michael / Borecki, Ingrid B / McCarthy, Mark I / Metspalu, Andres / Stefansson, Kari / Uitterlinden, André G / van Duijn, Cornelia M / Franke, Lude / Willer, Cristen J / Price, Alkes L / Lettre, Guillaume / Loos, Ruth J F / Weedon, Michael N / Ingelsson, Erik / O'Connell, Jeffrey R / Abecasis, Goncalo R / Chasman, Daniel I / Goddard, Michael E / Visscher, Peter M / Hirschhorn, Joel N / Frayling, Timothy M

    Nature genetics

    2014  Volume 46, Issue 11, Page(s) 1173–1186

    Abstract: Using genome-wide data from 253,288 individuals, we identified 697 variants at genome-wide significance that together explained one-fifth of the heritability for adult height. By testing different numbers of variants in independent studies, we show that ... ...

    Abstract Using genome-wide data from 253,288 individuals, we identified 697 variants at genome-wide significance that together explained one-fifth of the heritability for adult height. By testing different numbers of variants in independent studies, we show that the most strongly associated ∼2,000, ∼3,700 and ∼9,500 SNPs explained ∼21%, ∼24% and ∼29% of phenotypic variance. Furthermore, all common variants together captured 60% of heritability. The 697 variants clustered in 423 loci were enriched for genes, pathways and tissue types known to be involved in growth and together implicated genes and pathways not highlighted in earlier efforts, such as signaling by fibroblast growth factors, WNT/β-catenin and chondroitin sulfate-related genes. We identified several genes and pathways not previously connected with human skeletal growth, including mTOR, osteoglycin and binding of hyaluronic acid. Our results indicate a genetic architecture for human height that is characterized by a very large but finite number (thousands) of causal variants.
    MeSH term(s) Adult ; Analysis of Variance ; Body Height/genetics ; Genetic Variation/genetics ; Genetics, Population ; Genome-Wide Association Study/methods ; Humans ; Oligonucleotide Array Sequence Analysis ; Polymorphism, Single Nucleotide/genetics ; White People/genetics
    Language English
    Publishing date 2014-10-05
    Publishing country United States
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 1108734-1
    ISSN 1546-1718 ; 1061-4036
    ISSN (online) 1546-1718
    ISSN 1061-4036
    DOI 10.1038/ng.3097
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top